Avenue Therapeutics Inc
NASDAQ:ATXI
Avenue Therapeutics Inc Stock, NASDAQ:ATXI
1111 Kane Concourse, Suite 301, Bay Harbor Islands, Florida 33154
United States of America
Phone: +1.781.652.4500
Number of Employees: 2
Description
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.